Reduced CLU gene expression can lower the risk of AD and PD, according to genome-wide correlation studies that have identified the CLU gene as a well-established risk gene related to AD and PD (Karch and Goate, 2015; Lin et al., 2021). The gene discussed is CLU; the disease is Alzheimer disease.